نتایج جستجو برای: combination chemotherapy

تعداد نتایج: 478657  

A. Alibakhshi, A. Maddah Safaei, E. Esmati, F. Samiei, H. Nosrati, MS. Mirai Ashtiani, N. Khanjani, P. Haddad,

Background: Gastric cancer is an important health problem across the world. Chemotherapy in combination with local treatment is standard treatment for locally advanced gastroesophageal cancers. The purpose of this investigation was evaluation of response and tolerability to neoadjuvant EOX regimen in locoregionally advanced gastric cancer. Materials and Methods: patients with locoregionally adv...

Journal: :iranian journal of pathology 2009
kazem anvari abdolazim sedighi pashaki mahmoud reza kalantari mehdi seilanian toosi mohammad reza ghavam nasiri

background and objective: approximately half of patients with diffuse large b-cell lymphoma are cured with current chemotherapy regimens. the purpose of this study was to evaluate bax and bcl2 expression and their relationship with the response to chemotherapy. materials and methods this study was a prospective analysis on 44 patients with diffuse large b-cell lymphoma. their specimens were sta...

Journal: :international journal of hematology-oncology and stem cell research 0
zohreh sanaat hematology & oncology research center, tabriz university of medical sciences, tabriz ,iran. reza khalili hematology & oncology research center, tabriz university of medical sciences, tabriz ,iran. shohreh almasi immunology research center, tabriz university of medical sciences, tabriz, iran. mohammad reza aliparasti hematology & oncology research center, tabriz university of medical sciences, tabriz ,iran. seyed-mohammad tavangar pathology department, shariati hospital, tehran university of medical science, tehran, iran. aliakbar movasaghpoor hematology & oncology research center, tabriz university of medical sciences, tabriz ,iran.

introduction: acute myeloid leukemia is a malignant transformation of hematopoietic tissue, bone marrow infiltration of undifferentiated cells known as blasts that interfere with the production of normal cells. vascular endothelial growth factor (vegf) is persistently secreted from myeloid cells and high levels can be detected in patients' serum. methods: twenty-one aml patients, who were chemo...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2013
F A Raja N Counsell N Colombo J Pfisterer A du Bois M K Parmar I B Vergote A Gonzalez-Martin D S Alberts M Plante V Torri J A Ledermann

BACKGROUND The majority of women with ovarian cancer develop recurrent disease. For patients with a platinum-free interval of >6 months, platinum-based chemotherapy is a treatment of choice. The benefit of platinum-based combination chemotherapy in randomized trials varies, and a meta-analysis was carried out to gain more secure information on the size of the benefit of this treatment. MATERI...

Journal: :The New England journal of medicine 2012
Martin Fassnacht Massimo Terzolo Bruno Allolio Eric Baudin Harm Haak Alfredo Berruti Staffan Welin Carmen Schade-Brittinger André Lacroix Barbara Jarzab Halfdan Sorbye David J Torpy Vinzenz Stepan David E Schteingart Wiebke Arlt Matthias Kroiss Sophie Leboulleux Paola Sperone Anders Sundin Ilse Hermsen Stefanie Hahner Holger S Willenberg Antoine Tabarin Marcus Quinkler Christelle de la Fouchardière Martin Schlumberger Franco Mantero Dirk Weismann Felix Beuschlein Hans Gelderblom Hanneke Wilmink Monica Sender Maureen Edgerly Werner Kenn Tito Fojo Hans-Helge Müller Britt Skogseid

BACKGROUND Adrenocortical carcinoma is a rare cancer that has a poor response to cytotoxic treatment. METHODS We randomly assigned 304 patients with advanced adrenocortical carcinoma to receive mitotane plus either a combination of etoposide (100 mg per square meter of body-surface area on days 2 to 4), doxorubicin (40 mg per square meter on day 1), and cisplatin (40 mg per square meter on da...

Journal: :Oncology 2001
C M Rocha Lima C A Sherman F J Brescia C Y Brunson M R Green

Gemcitabine (Gemzar) and irinotecan (CPT-11, Camptosar) are active cytotoxic drugs against pancreatic cancer. Preclinical data evaluating the combination of gemcitabine and irinotecan suggest dose-dependent synergistic interactions in SCOG small-cell lung cancer and MCF-7 breast cancer cell lines. Two phase I trials of this combination have been reported to date: the day 1 and 8 every-3-week sc...

Journal: :The Tohoku journal of experimental medicine 1979
T Kurokawa I Nakao K Furukawa T Kanko T Yokoyama Y Ohashi

Three-drug therapy with Mitomycin-C (MMC), 5-fluorouracil (5-FU), and a nitrosourea derivative, ACNU, was carried out in 72 cases of carcinoma patients, mostly of stomach carcinoma. 1) According to Karnofsky's criteria, an effect of above I-A was observed in 10 of 35 cases (29%) treated with MFU-I (0.08 mg/kg of MMC, 10 mg/kg of 5-FU and 0.4-0.8 mg/kg of ACNU twice a week for the first two week...

2017
Sidharth Sonthalia Rahul Arora Ashu Abhishek

Sir, Taxanes, which are inhibitors of tubulin function in mitosis and used as cancer chemotherapy, are well known to be associated with onychopathy. Trastuzumab, a recombinant DNA‐derived humanized monoclonal antibody against the human epidermal growth factor receptor 2 protein (HER‐2) is used in combination with taxanes in advanced stage HER‐2 positive metastatic breast cancer.[1] We report th...

Journal: :The Medical journal of Malaysia 1993
A W Sufarlan B M Zainudin

Small cell lung cancer (SCLC) disseminates early and has poor prognosis. However, SCLC is highly chemosensitive, thus chemotherapy has been established as the primary mode of treatment. Seventeen patients (15 males and 2 females) with median age of 60 years (range 49 to 74 years) were treated with combination cyclophosphamide 750 mg/m2, adriamycin 40 mg/m2, vincristine 1.4 mg/m2 on day 1 and et...

2005
Sanford Kempin Burton J. Lee H. Tzvi Thaler Benjamin Koziner Suzanne Hecht Timothy Gee Zalmen Arlin Claudia Little David Straus Lillian Reich Elizabeth Phillips Hamid Al-Mondhiry Bayard Clarkson

1 1 10 Blood. Vol. 60. No. 5 (November). 1982 The M-2 protocol (vincristine. cyclophosphamide. BCNU. melphalan. and prednisone) was administered monthly to 63 evaluable patients with advanced chronic lymphocytic leukemia. Complete remission (absence of all clinical and bone marrow evidence of leukemia) and partial response (>50% decrease in organ enlargement and reduction of WBC count to below ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید